Evidence map›Paper›PMID 34313818›Full record

ReviewJournal of neurology2021

Covid-19 and Parkinson's disease: an overview.

S M Cartella, C Terranova, V Rizzo, A Quartarone, P Girlanda

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Dementia with Lewy bodies after COVID-19 infection with catatonia: A case report.PCN reports : psychiatry and clinical neurosciences · 2023
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Treatment paradigms in Parkinson's Disease and Covid-19.International review of neurobiology · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

S M CartellaDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy. sandycartella92@gmail.com.ORCID http://orcid.org/0000-0003-2636-8113
C TerranovaDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
V RizzoDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
A QuartaroneDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
P GirlandaDepartment of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
University of Messina · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In March 2020, WHO declared Covid-19 outbreak pandemic. There has been increasing evidence that frail, old, multi-pathological patients are at greater risk of developing severe Covid-19 infection than younger, healthy ones. Covid-19's impact on Parkinson's Disease (PD) patients could be analysed through both the influence on PD patients' health and their risk of developing severe Covid-19, and the consequences of lockdown and restrictive measures on mental and cognitive health on both patients and caregivers. Moreover, there are critical issues to be considered about patients' care and management through an unprecedented time like this. One important issue to consider is physiotherapy, as most patients cannot keep exercising because of restrictive measures which has profoundly impacted on their health. Lastly, the relationship between PD and Sars-Cov2 may be even more complicated than it seems as some studies have hypothesized a possible Covid-19-induced parkinsonism. Hereby, we review the state of the art about the relationship between Covid-19 and Parkinson's Disease, focusing on each of these five points.

Indexed as

COVID-19Parkinson DiseaseCommunicable Disease ControlHumansRNA, ViralSARS-CoV-2RNA, ViralCovid-19Movement disordersParkinson’s disease

Identifiers

PMID34313818
PMCPMC8313415
OpenAlexW3183621931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.